keyword
MENU ▼
Read by QxMD icon Read
search

Fecal microbiota transplant

keyword
https://www.readbyqxmd.com/read/29773467/human-microbiome-restoration-and-safety
#1
REVIEW
Eric Banan-Mwine Daliri, Charles Nkufi Tango, Byong H Lee, Deog-Hwan Oh
The human gut microbiome consists of many bacteria which are in symbiotic relationship with human beings. The gut microbial metabolism, as well as the microbial-host co-metabolism, has been found to greatly influence health and disease. Factors such as diet, antibiotic use and lifestyle have been associated with alterations in the gut microbial community and may result in several pathological conditions. For this reason, several strategies including fecal microbiota transplant and probiotic administration have been applied and proven to be feasible and effective in restoring the gut microbiota in humans...
May 9, 2018: International Journal of Medical Microbiology: IJMM
https://www.readbyqxmd.com/read/29771163/review-of-saccharomyces-boulardii-as-a-treatment-option-in-ibd
#2
Kavitha Sivananthan, Andreas Munk Petersen
CONTEXT: Review of the yeast Saccharomyces boulardii as a treatment option for the inflammatory bowel diseases (IBD) ulcerative colitis and Crohn's disease. OBJECTIVE: IBD is caused by an inappropriate immune response to gut microbiota. Treatment options could therefore be prebiotics, probiotics, antibiotics and/or fecal transplant. In this review, we have looked at the evidence for the yeast S. boulardii as a treatment option. MATERIAL AND METHODS: Searches in PubMed and the Cochrane Library with the MeSH words 'Saccharomyces boulardii AND IBD', 'Saccharomyces boulardii AND Inflammatory Bowel Disease', 'Saccharomyces boulardii AND ulcerative colitis' and 'Saccharomyces boulardii AND Crohn's disease' gave total a total of 80 articles...
May 17, 2018: Immunopharmacology and Immunotoxicology
https://www.readbyqxmd.com/read/29750050/does-the-internet-promote-the-unregulated-use-of-fecal-microbiota-transplantation-a-potential-public-health-issue
#3
Jonathan Philip Segal, Faisal Abbasi, Cynthia Kanagasundaram, Ailsa Hart
Introduction: The Internet has become an increasingly popular resource for medical information. Fecal microbiota transplantation (FMT) has changed the treatment of Clostridium difficile with cure rates of 81% following one infusion of FMT, further studies have since validated these findings. The Medicines and Health care Products Regulatory Agency has classified FMT as a medicine and hence should be only utilized in strict clinical settings. Methods: We searched Facebook, Twitter, Google, and YouTube using the words "Faecal Microbiota Transplantation" and "FMT"...
2018: Clinical and Experimental Gastroenterology
https://www.readbyqxmd.com/read/29748817/the-role-of-the-microbiome-for-human-health-from-basic-science-to-clinical-applications
#4
M Hasan Mohajeri, Robert J M Brummer, Robert A Rastall, Rinse K Weersma, Hermie J M Harmsen, Marijke Faas, Manfred Eggersdorfer
The 2017 annual symposium organized by the University Medical Center Groningen in The Netherlands focused on the role of the gut microbiome in human health and disease. Experts from academia and industry examined interactions of prebiotics, probiotics, or vitamins with the gut microbiome in health and disease, the development of the microbiome in early-life and the role of the microbiome on the gut-brain axis. The gut microbiota changes dramatically during pregnancy and intrinsic factors (such as stress), in addition to extrinsic factors (such as diet, and drugs) influence the composition and activity of the gut microbiome throughout life...
May 10, 2018: European Journal of Nutrition
https://www.readbyqxmd.com/read/29745777/current-experimental-and-future-treatments-in-inflammatory-bowel-disease-a-clinical-review
#5
Christian L Hvas, Mia Bendix, Anders Dige, Jens F Dahlerup, Jørgen Agnholt
Inflammatory bowel diseases (IBDs) may result from dysregulated mucosal immune responses directed toward the resident intestinal microbiota. This review describes the hallmark immunobiology of Crohn's disease and ulcerative colitis as well as therapeutic targets and mechanisms of action for current, experimental, and future treatments in IBD. Conventional therapies include 5-aminosalicylic acid, glucocorticosteroids, thiopurines, and methotrexate. Since 1997, monoclonal antibodies have gained widespread use...
May 10, 2018: Immunopharmacology and Immunotoxicology
https://www.readbyqxmd.com/read/29743453/-future-perspectives-on-fecal-microbiota-transplantation
#6
Shinta Mizuno, Kosaku Nanki, Takanori Kanai
No abstract text is available yet for this article.
2018: Nihon Shokakibyo Gakkai Zasshi, the Japanese Journal of Gastro-enterology
https://www.readbyqxmd.com/read/29742710/fecal-microbiota-transplantation-treatment-for-refractory-ulcerative-colitis-with-allergy-to-5-aminosalicylic-acid-a-case-report
#7
Hong-Gang Wang, Shi-Peng Liu, Tian-Heng Ma, Wei Yan, Jing-Fang Zhou, Yun-Tao Shi, Peng Shen, Xiao-Zhong Yang, Shang-Nong Wu
INTRODUCTION: Fecal microbiota transplantation (FMT) is currently being explored as a potential therapy for ulcerative colitis (UC). Here, we report the first case of a UC patient with allergy to 5-aminosalicylic acid (5-ASA) who underwent FMT and achieved clinical remission. CASE PRESENTATION: This patient had a 9-year history of UC and was allergic to 5-ASA. He suffered from gradually aggravated abdominal pain and frequent bloody diarrhea. There was a continuous distribution of superficial erosion and ulceration by colonoscopy...
May 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/29738579/baicd-gene-cluster-abundance-is-negatively-correlated-with-clostridium-difficile-infection
#8
Philipp Solbach, Patrick Chhatwal, Sabrina Woltemate, Evelina Tacconelli, Michael Buhl, Markus Gerhard, Christoph K Thoeringer, Maria J G T Vehreschild, Nathalie Jazmati, Jan Rupp, Michael P Manns, Oliver Bachmann, Sebastian Suerbaum
BACKGROUND: Clostridium difficile infection (CDI) is a major cause of hospital-acquired diarrhea. Secondary bile acids were shown to confer resistance to colonization by C. difficile. 7α-dehydroxylation is a key step in transformation of primary to secondary bile acids and required genes have been located in a single bile acid-inducible (bai) operon in C. scindens as well as in C. hiranonis, two Clostridium sp. recently reported to protect against C. difficile colonization. AIM: To analyze baiCD gene abundance in C...
2018: PloS One
https://www.readbyqxmd.com/read/29733457/age-related-changes-in-the-gut-microbiota-influence-systemic-inflammation-and-stroke-outcome
#9
Monica S Spychala, Venugopal Reddy Venna, Michal Jandzinski, Sarah J Doran, David J Durgan, Bhanu Priya Ganesh, Nadim J Ajami, Nagireddy Putluri, Joerg Graf, Robert M Bryan, Louise D McCullough
Objective Chronic systemic inflammation contributes to the pathogenesis of many age-related diseases. Although not well understood, alterations in the gut microbiota, or dysbiosis, may be responsible for age-related inflammation. Methods Using stroke as a disease model, we tested the hypothesis that a youthful microbiota, when established in aged mice, produces positive outcomes following ischemic stroke. Conversely, an aged microbiota, when established in young mice, produces negative outcomes after stroke...
May 7, 2018: Annals of Neurology
https://www.readbyqxmd.com/read/29728643/interleukin-22-deficiency-and-microbiota-contribute-to-the-exacerbation-of-toxoplasma-gondii-induced-intestinal-inflammation
#10
A Couturier-Maillard, N Froux, J Piotet-Morin, C Michaudel, L Brault, J Le Bérichel, A Sénéchal, P Robinet, P Chenuet, S Jejou, L Dumoutier, J C Renauld, J Iovanna, S Huber, Vfj Quesniaux, H Sokol, B Ryffel
Upon oral infection with Toxoplasma gondii cysts (76 K strain) tachyzoites are released into the intestinal lumen and cross the epithelial barrier causing damage and acute intestinal inflammation in C57BL/6 (B6) mice. Here we investigated the role of microbiota and IL-22 in T.gondii-induced small intestinal inflammation. Oral T.gondii infection in B6 mice causes inflammation with IFNγ and IL-22 production. In IL-22-deficient mice, T.gondii infection augments the Th1 driven inflammation. Deficiency in either IL-22bp, the soluble IL-22 receptor or Reg3γ, an IL-22-dependent antimicrobial lectin/peptide, did not reduce inflammation...
May 4, 2018: Mucosal Immunology
https://www.readbyqxmd.com/read/29728388/fecal-microbiota-transplantation-in-experimental-ulcerative-colitis-reveals-associated-gut-microbial-and-host-metabolic-reprogramming
#11
Zhixiang Yan, Xue-Jiao Gao, Ting Li, Bin Wei, Panpan Wang, Ying Yang, Ru Yan
Fecal microbiota transplantation (FMT) is gaining attention for the treatment of ulcerative colitis (UC). Data from individual case studies have suggested that FMT may be beneficial for UC but the detailed microbial and molecular basis remains unknown. Here, we employ 16S rRNA gene sequencing and metabolomics to investigate the influence of FMT on gut microbial community composition and host metabolism in the dextran sulfate sodium (DSS) induced UC rat model. The findings from this pilot study suggest that FMT from normal donors to UC recipients could alleviate UC symptoms without close resemblance of donor's gut microbial and metabolic pattern...
May 4, 2018: Applied and Environmental Microbiology
https://www.readbyqxmd.com/read/29717179/transplantation-of-human-microbiota-into-conventional-mice-durably-reshapes-the-gut-microbiota
#12
Laura Wrzosek, Dragos Ciocan, Patrick Borentain, Madeleine Spatz, Virginie Puchois, Cindy Hugot, Gladys Ferrere, Camille Mayeur, Gabriel Perlemuter, Anne-Marie Cassard
Human microbiota-associated (HMA) mice are an important model to study the relationship between liver diseases and intestinal microbiota. We describe a new method to humanize conventional mice based on bowel cleansing with polyethylene glycol followed by fecal microbiota transplantation (FMT) from a human donor. Four successive bowel cleansings were sufficient to empty the intestine and decrease the microbiota by 90%. We then compared four different strategies based on the frequency of FMT over four weeks: (1) twice a week; (2) once a week; (3) two FMTs; (4) one FMT...
May 1, 2018: Scientific Reports
https://www.readbyqxmd.com/read/29709869/a-repeat-offender-recurrent-extraintestinal-clostridium-difficile-infection-following-fecal-microbiota-transplantation
#13
Bradley J Gardiner, Cheleste M Thorpe, Nicholas V Pinkham, Laura A McDermott, Seth T Walk, David R Snydman
Extraintestinal infection with Clostridium difficile has been reported but remains uncommon. Treatment of this unusual complication is complex given the limitations of current therapeutic options. Here we report a novel case of recurrent extraintestinal C. difficile infection that occurred following fecal microbiota transplantation. Using whole genome sequencing, we confirmed recrudescence rather than reinfection was responsible. The patient ultimately responded to prolonged, targeted antimicrobial therapy informed by susceptibility testing...
April 21, 2018: Anaerobe
https://www.readbyqxmd.com/read/29705917/management-of-hepatic-encephalopathy-not-responsive-to-first-line-treatments
#14
REVIEW
Silvia Nardelli, Lorenzo Ridola, Stefania Gioia, Oliviero Riggio
PURPOSE OF REVIEW: Hepatic encephalopathy (HE) is a neuropsychiatric syndrome that occurs in up to 30% of patients with cirrhosis. HE may be a consequence of pure liver failure, as in patients with fulminant hepatitis, or of the combination of liver failure and portal-systemic shunting, as in patients with liver cirrhosis. Episodes of HE are usually related to precipitating events, such as infections or gastrointestinal bleeding; a minority of cirrhotic patients experienced a chronic HE, refractory to standard medical treatment...
April 28, 2018: Current Treatment Options in Gastroenterology
https://www.readbyqxmd.com/read/29705121/dysbiosis-of-gut-microbiota-and-microbial-metabolites-in-parkinson-s-disease
#15
REVIEW
Meng-Fei Sun, Yan-Qin Shen
Gut microbial dysbiosis and alteration of microbial metabolites in Parkinson's disease (PD) have been increasingly reported. Dysbiosis in the composition and abundance of gut microbiota can affect both the enteric nervous system and the central nervous system (CNS), indicating the existence of a microbiota-gut-brain axis and thereby causing CNS diseases. Disturbance of the microbiota-gut-brain axis has been linked to specific microbial products that are related to gut inflammation and neuroinflammation. Future directions should therefore focus on the exploration of specific gut microbes or microbial metabolites that contribute to the development of PD...
April 26, 2018: Ageing Research Reviews
https://www.readbyqxmd.com/read/29703246/clostridium-difficile-cure-with-fecal-microbiota-transplantation-in-a-child-with-pompe-disease-a-case-report
#16
D E Dow, P C Seed
BACKGROUND: Recurrent Clostridium difficile infection is a growing problem among children due to both the increasing survival of medically fragile children with complicated chronic medical conditions resulting in prolonged antibiotic exposure and hospitalization and the emergence of strains of Clostridium difficile that are hypervirulent and associated with high rates of relapse. CASE PRESENTATION: This case describes a medically complex 21-month-old Hispanic girl with Pompe disease and B cell immunodeficiency with recurrent Clostridium difficile infection refractory to antimicrobial management...
April 28, 2018: Journal of Medical Case Reports
https://www.readbyqxmd.com/read/29696802/the-role-of-fecal-microbiota-transplantation-in-inflammatory-bowel-disease
#17
REVIEW
Irene D'Odorico, Stefano Di Bella, Jacopo Monticelli, Daniele Roberto Giacobbe, Emma Boldock, Roberto Luzzati
Increasing evidence suggests the key role of altered intestinal microbiota in the pathogenesis of inflammatory bowel disease (IBD). Management strategies involving immune modulation are effective and widely used, but treatment failures and side effects occur. Fecal microbiota transplantation (FMT) provides a novel, perhaps complementary, strategy to restore the abnormal gut microbiome in patients with IBD. This narrative review summarizes the available efficacy and safety data on the use of FMT in IBD patients...
April 25, 2018: Journal of Digestive Diseases
https://www.readbyqxmd.com/read/29694952/dysbiosis-in-functional-bowel-disorders
#18
Paul Enck, Nazar Mazurak
Functional bowel disorders (FBD) resemble a group of diseases of the gastrointestinal (GI) tract that are without a clear pathogenesis; the best known is probably the "irritable bowel syndrome" (IBS). Only recently we have been able to explore the role of the gut microbiota in FBD due to progress in microbiological analytic techniques. There are different ways to explore the role of the gut microbiota and its dysbiosis in FBD. Comparison of the microbial composition in a group of patients with FBD, for example, with IBS to a group of healthy volunteers is one way...
April 25, 2018: Annals of Nutrition & Metabolism
https://www.readbyqxmd.com/read/29691757/microbiota-transplantation-concept-methodology-and-strategy-for-its-modernization
#19
REVIEW
Faming Zhang, Bota Cui, Xingxiang He, Yuqiang Nie, Kaichun Wu, Daiming Fan
Fecal microbiota transplantation (FMT) has become a research focus of biomedicine and clinical medicine in recent years. The clinical response from FMT for different diseases provided evidence for microbiota-host interactions associated with various disorders, including Clostridium difficile infection, inflammatory bowel disease, diabetes mellitus, cancer, liver cirrhosis, gut-brain disease and others. To discuss the experiences of using microbes to treat human diseases from ancient China to current era should be important in moving standardized FMT forward and achieving a better future...
April 24, 2018: Protein & Cell
https://www.readbyqxmd.com/read/29688901/safety-and-efficacy-of-encapsulated-fecal-microbiota-transplantation-for-recurrent-clostridium-difficile-infection-a-systematic-review
#20
Umair Iqbal, Hafsa Anwar, Muhammad A Karim
BACKGROUND AND AIMS: Fecal microbial transplantation (FMT) has been shown to be effective for the treatment of recurrent clostridium difficile infection (CDI). The efficacy and safety of freeze-dried encapsulated FMT for the treatment of recurrent CDI is unclear. We performed a systematic review to evaluate and analyze the current evidence in this respect. MATERIALS AND METHODS: A systematic literature search was performed using the PubMed, Embase, and Medline databases until December 2017 to identify all original studies that investigated the role of administration of encapsulated FMT in recurrent CDI...
April 23, 2018: European Journal of Gastroenterology & Hepatology
keyword
keyword
20139
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"